Skull base osteomyelitis in the Auckland region
Australian Journal of Otolaryngology · 2023-03 · 6 · 0-0
DOI: 10.21037/ajo-22-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian Journal of Otolaryngology, 2023-03. Verfasst von Henry Emanuel und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Skull base osteomyelitis (SBO) inflicts significant morbidity, mortality, and health resource burden in our region. Despite an increasing literature on the condition, and rising incidence in parts of the world, there continues to be a lack of consensus on prognostication, treatment duration, and disease monitoring methods.
Methods
A 16-year retrospective cohort study of patients presenting with SBO to the Auckland region between January 2004 and December 2019 were identified by discharge code, and electronic records were examined. Variables at presentation (age >70, diabetes mellitus, facial nerve palsy, and smoking) were assessed for their influence on clinical outcome. Culture methods and relative yield by site was investigated, and a complete review of microbiology is presented. Clinical, Radiologic, and Inflammatory outcomes are defined and assessed for correlation in an attempt to guide disease monitoring.
Results
Sixty-three patients presented, and the annual incidence increased over time. Pasifika were significantly overrepresented. Pseudomonas aeruginosa was the predominant pathogen cultured, and ear canal granulation tissue was the most useful in identifying the target organism. Fifty-six patients completed at least 12 months follow up. Of these, 28 (50%) were cured, 16 (28%) relapsed, and 12 (21%) failed their initial treatment course. Relapse of SBO could not be predicted by the variables tested in this study. Concordant raised inflammatory markers and persistent radiographic evidence of disease is reliably seen in those that fail treatment.
Conclusions
A revised treatment algorithm is proposed containing guidance on tissue culture methods; and suggests a longer duration of intravenous therapy. Clinical follow up and multidisciplinary management beyond 12 months from treatment is further supported.
Zitieren
APA
Emanuel, H., Neeff, M., Thomas, M., & Bryce, A. (2023). Skull base osteomyelitis in the Auckland region. Australian Journal of Otolaryngology, 6, 0-0. https://doi.org/10.21037/ajo-22-23
Vancouver
Emanuel H, Neeff M, Thomas M, Bryce A. Skull base osteomyelitis in the Auckland region. Australian Journal of Otolaryngology. 2023;6:0-0. doi:10.21037/ajo-22-23
BibTeX
@article{Emanuel2023,
author = {Emanuel, Henry and Neeff, Michel and Thomas, Mark and Bryce, Aliya},
title = {Skull base osteomyelitis in the Auckland region},
journal = {Australian Journal of Otolaryngology},
year = {2023},
volume = {6},
pages = {0--0},
doi = {10.21037/ajo-22-23}
}
EUVIMED